New Approaches to the Drug Molecule: Essential Oil and Pyridazinone Derivative Molecules

Year 2025, Volume: 4 Issue: 3, 166 - 174, 19.12.2025

Okan Aykaç , Umut Okur Recep Ogün Demirci , Tuba Öner Gülce Taşkor Önel , İrem Bozbey Merde

https://doi.org/10.71133/anatphar.1811622

Abstract

In this study, it was aimed to synthesise a new pyridazinone derivative compound with the potential to act as an acetylcholinesterase (AChE) inhibitor in the treatment of Alzheimer's disease and to encapsulate it into biodegradable poly(lactic-co-glycolic acid) (PLGA) microparticles together with lavender essential oil. The pyridazinone derivative compound was synthesised in five steps and its structure was elucidated by NMR and FTIR analyses. PLGA biopolymer was prepared by ring opening polymerisation and the pyridazinone-lavender oil mixture was encapsulated into microparticles by solvent evaporation method. Encapsulation efficiency was determined spectrophotometrically and morphological analyses were performed by scanning electron microscopy (SEM). NMR and FTIR analyses showed that the target compound was successfully synthesised. According to GPC analysis, the average molecular weight of PLGA was found to be 3.019 Da and the PDI value was 1.408. SEM images showed that the microparticles were spherical, with smooth surface and in the size range of 5-20 µm. The encapsulation efficiency was determined as 78%. PLGA microparticles containing pyridazinone derivative compound and lavender oil can be considered as potential neuroprotective and anticholinesterase agents that can be used in Alzheimer's disease. This system, which provides controlled drug release thanks to its biodegradable structure, is recommended to be evaluated in advanced in vitro AChE/BuChE inhibition and cell culture studies.

Keywords

Alzheimer , Essential oil , Microencapsulation , PLGA , Pyridazinone

References

• Sang, Z., Wang, K., Dong, J., & Tang, L. (2022). Alzheimer’s disease: Updated multi-targets therapeutics are in clinical and in progress. European Journal of Medicinal Chemistry, 238.
• Breijyeh, Z., & Karaman, R. (2020b). Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules (Basel, Switzerland), 25(24).
• Areosa Sastre, A., Sherriff, F., & McShane, R. (2005). Memantine for dementia. The Cochrane Database of Systematic Reviews, 3.
• Fish, P. V., Steadman, D., Bayle, E. D., & Whiting, P. (2019b). New approaches for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters, 29(2), 125–133.
• Alghamdi, S., & Asif, M. (2021). Role of pyridazine analogs as acetylcholinesterase inhibitor: An approach for management of alzheimer’s disease. Eurasian Chemical Communications, 3(7), 435–442.
• Kilic, B., Erdogan, M., Gulcan, H. O., Aksakal, F., Oruklu, N., Bagriacik, E. U., & Dogruer, D. S. (2019). Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors. Medicinal Chemistry (Shariqah (United Arab Emirates)), 15(1), 59–76.
• Soheili, M., & Salami, M. (2019). Lavandula angustifolia biological characteristics: An in vitro study. Journal of Cellular Physiology, 234(9), 16424–16430.
• Xu, Q., Wang, Y., Xu, J., Sun, M., Tian, H., Zuo, D., Guan, Q., Bao, K., Wu, Y., & Zhang, W. (2016). Synthesis and Bioevaluation of 3,6-Diaryl-[1,2,4]triazolo[4,3-b] Pyridazines as Antitubulin Agents. ACS Medicinal Chemistry Letters, 7(12), 1202–1206.
• Botvin, V., Karaseva, S., Salikova, D., & Dusselier, M. (2021). Syntheses and chemical transformations of glycolide and lactide as monomers for biodegradable polymers. Polymer Degradation and Stability, 183, 109427.
• Pan, Z., & Ding, J. (2012). Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine. Interface Focus, 2(3), 366–377.
• Önel, G. T. (2023). Synthesis and Characterization of Poly(lactic-co-glycolic acid) Derived with LGlutamic Acid and L-Aspartic Acid. Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 16(1), 155–168.
• Freitas, S., Merkle, H. P., & Gander, B. (2005). Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. Journal of Controlled Release : Official Journal of the Controlled Release Society, 102(2), 313–332.
• Aubert-Pouëssel, A., Venier-Julienne, M. C., Clavreul, A., Sergent, M., Jollivet, C., Montero-Menei, C. N., Garcion, E., Bibby, D. C., Menei, P., & Benoit, J. P. (2004). In vitro study of GDNF release from biodegradable PLGA microspheres. Journal of Controlled Release, 95(3), 463–475.